Neurocrine Seizure Drug Failure Draws Concern For Additional Program

 
• By Alaric DeArment
  
Neurocrine announced the failure of two Phase II trials of drugs for seizures and anhedonia • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D